Follow
Shailendra Kumar Verma
Shailendra Kumar Verma
La Jolla Institute for Immunology
Verified email at lji.org
Title
Cited by
Cited by
Year
Japanese encephalitis outbreak, India, 2005
M Parida, PK Dash, NK Tripathi, S Sannarangaiah, P Saxena, S Agarwal, ...
Emerging infectious diseases 12 (9), 1427, 2006
1732006
East Central South African genotype as the causative agent in reemergence of Chikungunya outbreak in India
PK Dash, MM Parida, SR Santhosh, SK Verma, NK Tripathi, S Ambuj, ...
Vector-Borne and Zoonotic Diseases 7 (4), 519-528, 2007
1002007
Plague Vaccine Development: Current Research & Future Trends.
SK Verma, U Tueja
Frontiers in Immunology 7, 602, 2016
632016
Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate
P Pattnaik, JP Babu, SK Verma, V Tak, PVL Rao
Journal of Chromatography B 846 (1-2), 184-194, 2007
512007
Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood …
NK Singh, V Kundumani-Sridharan, S Kumar, SK Verma, S Kotla, H Mukai, ...
Journal of Biological Chemistry 287 (43), 36291-36304, 2012
422012
Non-muscle myosin IIA transports a Golgi glycosyltransferase to the endoplasmic reticulum by binding to its cytoplasmic tail
A Petrosyan, MF Ali, SK Verma, H Cheng, PW Cheng
The international journal of biochemistry & cell biology 44 (7), 1153-1165, 2012
372012
Use of a recombinant Burkholderia intracellular motility a protein for immunodiagnosis of glanders
S Kumar, P Malik, SK Verma, V Pal, V Gautam, C Mukhopadhyay, GP Rai
Clinical and Vaccine Immunology 18 (9), 1456-1461, 2011
312011
Overexpression, purification, and immunogenicity of recombinant porin proteins of Salmonella enterica Serovar Typhi (S. Typhi)
SK Verma, V Gautam, K Balakrishna, S Kumar
Journal of microbiology and biotechnology 19 (9), 1034-1040, 2009
302009
New-age vaccine adjuvants, their development, and future perspective
SK Verma, P Mahajan, NK Singh, A Gupta, R Aggarwal, R Rappuoli, ...
Frontiers in Immunology 14, 1043109, 2023
292023
A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity
JA Regla-Nava, YT Wang, CR Fontes-Garfias, Y Liu, T Syed, ...
Cell reports 39 (2), 2022
252022
Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice
SK Verma, S Kumar, N Gupta, S Vedi, SM Bhattacharya, PVL Rao
Vaccine 27 (49), 6905-6909, 2009
232009
Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cells
SK Verma, N Gupta, P Pattnaik, JP Babu, PV Lakshmana Rao, S Kumar
Protein and peptide letters 16 (11), 1334-1341, 2009
222009
HSP70 Domain II of Mycobacterium tuberculosis Modulates Immune Response and Protective Potential of F1 and LcrV Antigens of Yersinia pestis in a Mouse Model
L Batra, SK Verma, DP Nagar, N Saxena, P Pathak, SC Pant, U Tuteja
PLoS neglected tropical diseases 8 (12), e3322, 2014
212014
Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice
SK Verma, S Jain, S Kumar
World Journal of Microbiology and Biotechnology 28, 2487-2495, 2012
192012
A recombinant trivalent fusion protein F1–LcrV–HSP70 (II) augments humoral and cellular immune responses and imparts full protection against Yersinia pestis
SK Verma, L Batra, U Tuteja
Frontiers in Microbiology 7, 206697, 2016
182016
Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications
TN Athmaram, S Saraswat, P Misra, S Shrivastava, AK Singh, SK Verma, ...
Virus genes 46, 219-230, 2013
182013
Molecular cloning, purification and characterisation of myosin of human lymphatic filarial parasite Brugia malayi
SK Verma, I Bansal, S Vedi, JK Saxena, VM Katoch, SM Bhattacharya
Parasitology research 102, 481-489, 2008
102008
Search for new prototypes for the chemotherapy of filariasis: a chemotherapeutic and biochemical approach
P Bajpai, SK Verma, D Katiyar, N Tewari, RP Tripathi, I Bansal, JK Saxena, ...
Parasitology research 95, 383-390, 2005
102005
Vaccine Potential of a Recombinant Bivalent Fusion Protein LcrV-HSP70 Against Plague and Yersiniosis
A Gupta, B Narayan, S Kumar, SK Verma
Frontiers in Immunology 11 (988), 2020
92020
Escherichia coli expressed flagellin C (FliC) of Salmonella Typhi improved the protective efficacy of YopE against plague infection
SK Verma, A Gupta, L Batra, U Tuteja
Vaccine 37 (1), 19-24, 2019
82019
The system can't perform the operation now. Try again later.
Articles 1–20